# Definium Therapeutics, Inc.: Form 8-K, filed Jan 29, 2026

- Company: [Definium Therapeutics, Inc.](/companies/dftx.md) (CIK 1813814)
- Form: 8-K
- Filed: 2026-01-29
- Accepted by EDGAR: Jan 29, 2026, 07:30 ET
- Period: 2026-01-28
- Accession: 0001193125-26-028186
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1813814/000119312526028186/dftx-20260128.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1813814/000119312526028186/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1813814/000119312526028186/dftx-20260128.htm

Filed Jan 29, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-028186. Last ingested by Listed: Nov 10, 2026, 02:38 ET. No prices; not investment advice.